ArticleJournal of cellular and molecular medicine2011

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.

Xiaoli Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.